LIVER

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study

J A Davila¹, R O Morgan¹, Y Shaib², K A McGlynn³, H B El-Serag²

¹ Section of Health Services Research, Houston Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas, USA
² Section of Health Services Research, and Section of Gastroenterology, Houston Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas, USA
³ Division of Cancer Epidemiology and Genetics, NCI/DHHS, USA

Correspondence to:
Correspondence to:
Dr H B El-Serag
Houston Veterans Affairs Medical Center, 2002 Holcombe Blvd. (152), Houston, TX 77030, USA; hasheme{at}bcm.tmc.edu

Background: Diabetes has been associated with an increased risk of hepatocellular carcinoma (HCC) in studies of referred patients. This is the first population based case control study in the USA to examine this association while adjusting for other major risk factors related to HCC.

Methods: We used the Surveillance Epidemiology and End-Results Program (SEER)-Medicare linked database to identify patients aged 65 years and older diagnosed with HCC and randomly selected non-cancer controls between 1994 and 1999. Only cases and controls with continuous Medicare enrolment for three years prior to the index date were examined. Inpatient and outpatient claims files were searched for diagnostic codes indicative of diabetes, hepatitis C virus (HCV), hepatitis B virus (HBV), alcoholic liver disease, and haemochromatosis. HCC patients without these conditions were categorised as idiopathic. Unadjusted and adjusted odds ratios were calculated in logistic regression analyses.

Results: We identified 2061 HCC patients and 6183 non-cancer controls. Compared with non-cancer controls, patients with HCC were male (66% v 36%) and non-White (34% v 18%). The proportion of HCC patients with diabetes (43%) was significantly greater than non-cancer controls (19%). In multiple logistic regression analyses that adjusted for demographics features and other HCC risk factors (HCV, HBV, alcoholic liver disease, and haemochromatosis), diabetes was associated with a threefold increase in the risk of HCC. In a subset of patients without these major risk factors, the adjusted odds ratio for diabetes declined but remained significant (adjusted odds ratio 2.87 (95% confidence interval 2.49–3.30)). A significant positive interaction between HCV and diabetes was detected (p<0.0001). Similar findings persisted in analyses restricted to diabetes recorded between two and three years prior to HCC diagnosis.

Conclusions: Diabetes is associated with a 2–3-fold increase in the risk of HCC, regardless of the presence of other major HCC risk factors. Findings from this population based study suggest that diabetes is an independent risk factor for HCC.

Abbreviations: SEER, Surveillance, Epidemiology, and End-Results Program; HCC, hepatocellular carcinoma; HBV, hepatitis B virus; HCV, hepatitis C virus; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; HMO, health maintenance organisation; OR, odds ratio; HIV, human immunodeficiency virus

Keywords: diabetes; hepatocellular carcinoma; Surveillance Epidemiology and End-Results Program; epidemiology; hepatoma

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Digest

Robin Spiller
Gut 2005 54: 443. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Dowman, J. K., Tomlinson, J.W., Newsome, P.N. (2009). Pathogenesis of non-alcoholic fatty liver disease. QJM 0: hcp158v1-hcp158 [Full Text]  
• Wang, C.-S., Yao, W.-J., Chang, T.-T., Wang, S.-T., Chou, P. (2009). The Impact of Type 2 Diabetes on the Development of Hepatocellular Carcinoma in Different Viral Hepatitis Statuses. Cancer Epidemiol. Biomarkers Prev. 18: 2054-2060 [Abstract] [Full Text]  
• Bhala, N., Bhopal, R., Brock, A., Griffiths, C., Wild, S. (2009). Alcohol-related and hepatocellular cancer deaths by country of birth in England and Wales: analysis of mortality and census data. J Public Health (Oxf) 31: 250-257 [Abstract] [Full Text]  
• Shimizu, M., Shirakami, Y., Iwasa, J., Shiraki, M., Yasuda, Y., Hata, K., Hirose, Y., Tsurumi, H., Tanaka, T., Moriwaki, H. (2009). Supplementation with Branched-chain Amino Acids Inhibits Azoxymethane-induced Colonic Preneoplastic Lesions in Male C57BL/KsJ-db/db Mice. Clin. Cancer Res. 15: 3068-3075 [Abstract] [Full Text]  
• Lemke, L. B, Rogers, A. B, Nambiar, P. R, Fox, J. G (2008). Obesity and non-insulin-dependent diabetes mellitus in Swiss-Webster mice associated with late-onset hepatocellular carcinoma. J Endocrinol 199: 21-32 [Abstract] [Full Text]  
• Veldt, B. J., Heathcote, E. J., Wedemeyer, H., Reichen, J., Hofmann, W. P., Zeuzem, S., Manns, M. P., Hansen, B. E., Schalm, S. W., Janssen, H. L.A. (2007). Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis. ANN INTERN MED 147: 677-684 [Abstract] [Full Text]  
• Travier, N, Jeffreys, M, Brewer, N, Wright, C., Cunningham, C., Hornell, J, Pearce, N (2007). Association between glycosylated hemoglobin and cancer risk: a New Zealand linkage study. Ann Oncol 18: 1414-1419 [Abstract] [Full Text]  
• West, J., Brousil, J., Gazis, A., Jackson, L., Mansell, P., Bennett, A., Aithal, G.P. (2006). Elevated serum alanine transaminase in patients with type 1 or type 2 diabetes mellitus.. QJM 99: 871-876 [Abstract] [Full Text]  
• Inoue, M., Iwasaki, M., Otani, T., Sasazuki, S., Noda, M., Tsugane, S., for the Japan Public Health Center-Based Prospecti, (2006). Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan.. Arch Intern Med 166: 1871-1877 [Abstract] [Full Text]  
• Muir, M. (2006). Hygieia. J. Epidemiol. Community Health 60: 280-280 [Full Text]  
• Dombrowski, F., Mathieu, C., Evert, M. (2006). Hepatocellular Neoplasms Induced by Low-Number Pancreatic Islet Transplants in Autoimmune Diabetic BB/Pfd Rats. Cancer Res. 66: 1833-1843 [Abstract] [Full Text]  
• Wilson, J. F. (2005). Liver Cancer on the Rise. ANN INTERN MED 142: 1029-1032 [Full Text]